Cetera Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $619K | Buy |
60,800
+9,977
| +20% | +$102K | ﹤0.01% | 1465 |
|
|
2023
Q4 | $572K | Buy |
+50,823
| New | +$572K | 0.01% | 1048 |
|
|
2023
Q1 | – | Sell |
-10,100
| Closed | -$166K | – | 1644 |
|
|
2022
Q4 | $166K | Sell |
10,100
-2,300
| -19% | -$37.8K | ﹤0.01% | 1468 |
|
|
2022
Q3 | $158K | Sell |
12,400
-4,700
| -27% | -$59.9K | ﹤0.01% | 1170 |
|
|
2022
Q2 | $200K | Sell |
17,100
-1,400
| -8% | -$16.4K | ﹤0.01% | 1242 |
|
|
2022
Q1 | $113K | Buy |
+18,500
| New | +$113K | ﹤0.01% | 1351 |
|